论文部分内容阅读
通过琼脂凝胶电泳将血清中小分子HBeAg 和大分子HBeAg 分开,再用固相联免疫法作HBeAg 定量测定,HBsAg 和抗-HBe 分别用Auszyme Ⅱ和Abbott HBe EIA 测定。结果:9例无肝组织病理改变或有非特异性反应性肝炎患者血清中大分子HBeAg占总HBeAg 的7.3%±3.4%,32例慢性迁延性肝
The small molecule HBeAg and the large molecule HBeAg in serum were separated by agarose gel electrophoresis, and then the HBeAg quantitative determination was made by solid phase immunosorbent assay. The HBsAg and anti-HBe were measured by Auszyme Ⅱ and Abbott HBe EIA respectively. Results: The serum level of HBeAg was 7.3% ± 3.4% of the total in 9 cases of non-liver tissue pathological changes or non-specific reactive hepatitis, and 32 cases of chronic persistent liver